Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II Study-Reference-Cited by-同舟云学术

Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II Study

Published:2010-04-01 Issue:4 Volume:53 Page:456-463
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Gatell Jose M,Katlama Christine,Grinsztejn Beatriz,Eron Joseph J,Lazzarin Adriano,Vittecoq Daniel,Gonzalez Charles J,Danovich Robert M,Wan Hong,Zhao Jing,Meibohm Anne R,Strohmaier Kim M,Harvey Charlotte M,Isaacs Robin D,Nguyen Bach-Yen T

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference12 articles.

1. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.;Hazuda;Science,2000

2. Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection.;Markowitz;J Acquir Immune Defic Syndr,2009

3. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomized controlled trial.;Grinsztejn;Lancet,2007

4. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America.;Aberg;Clin Infect Dis,2009

5. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.;Cooper;N Engl J Med,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins;Frontiers in Microbiology;2022-07-14

2. Evidence for Disruption of Mg2+ Pair as a Resistance Mechanism Against HIV-1 Integrase Strand Transfer Inhibitors;Frontiers in Molecular Biosciences;2020-08-20

3. Detection of novel HIV-1 drug resistance mutations by support vector analysis of deep sequence data and experimental validation;2019-10-14

4. Raltegravir-Induced Adaptations of the HIV-1 Integrase: Analysis of Structure, Variability, and Mutation Co-occurrence;Frontiers in Microbiology;2019-09-03

5. Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis;Open Forum Infectious Diseases;2019-02-12